https://www.globenewswire.com/news-release/2024/12/27/3002246/0/en/PainReform-Provides-Further-Update-on-Phase-3-Clinical-Trial-of-PRF-110.html
PainReform Provides Further Update on Phase 3 Clinical
TEL AVIV, Israel, Dec. 27, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (
providesupdatephaseclinical